Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 3 7Phase 1/2 4Phase 1 4Phase NA 2Phase 4 1

Status

Withdrawn 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Dermatologic 1

Conditions

Lymphoma 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Large B-Cell, Diffuse 6Leukemia 5Nausea 4Lymphoma, Non-Hodgkin 4Central Nervous System Neoplasms 4Vomiting 3Sarcoma 3Neuroblastoma 3Spinal Cord Neoplasms 2Retinoblastoma 2Oligodendroglioma 2Lymphoma, Large-Cell, Anaplastic 2Sezary Syndrome 1Recurrence 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Mycosis Fungoides 1Multiple Myeloma 1Motor Activity 1Medulloblastoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Leukemia, Biphenotypic, Acute 1Immunoblastic Lymphadenopathy 1HIV Infections 1

Interventions

Peripheral Blood Stem Cell Transplantation 7Whole-Body Irradiation 6Cyclosporine 5fludarabine phosphate 4Melphalan 4Mycophenolic Acid 3Methotrexate 3Etoposide 3Cytarabine 3Cyclophosphamide 3Carmustine 3Busulfan 3Antilymphocyte Serum 3Vincristine 2Thiotepa 2Prednisone 2Magnetic Resonance Spectroscopy 2Leucovorin 2Doxorubicin 2Carboplatin 2thymoglobulin 1plerixafor 1etoposide phosphate 1denileukin diftitox 1amuvatinib 1Vindesine 1Vinblastine 1Triamcinolone Acetonide 1Therapeutics 1Salvia hispanica seed extract 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, Large-Cell, Anaplastic × Vincristine × Clear all
NCT00513188 2016-12-15

Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin Lymphoma

University of Miami

Phase NA Withdrawn
DermatologicLymphoid

Immunoblastic Lymphadenopathy, Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Extranodal NK-T-Cell

NCT00110006 2010-06-11

Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma

Case Comprehensive Cancer Center

Phase NA Withdrawn
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡